Contineum Therapeutics, Inc. (CTNM)
17.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
17.04
0.00 (0.00%)
After-Hours: 17:12
Contineum Therapeutics Market Cap : 641.12M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 641.31M |
| August 24, 2026 | 625.51M |
| August 21, 2026 | 646.57M |
| August 20, 2026 | 602.57M |
| August 19, 2026 | 602.57M |
| August 18, 2026 | 545.39M |
| August 17, 2026 | 546.52M |
| August 14, 2026 | 533.73M |
| August 13, 2026 | 575.48M |
| August 12, 2026 | 563.45M |
| August 11, 2026 | 557.43M |
| August 10, 2026 | 545.02M |
| August 07, 2026 | 565.71M |
| August 06, 2026 | 577.37M |
| August 05, 2026 | 574.36M |
| August 04, 2026 | 598.05M |
| August 03, 2026 | 599.18M |
| July 31, 2026 | 582.63M |
| July 30, 2026 | 592.41M |
| July 29, 2026 | 540.88M |
| July 28, 2026 | 532.61M |
| July 27, 2026 | 521.32M |
| July 24, 2026 | 525.65M |
| July 23, 2026 | 537.24M |
| July 22, 2026 | 550.70M |
| Date | Value |
|---|---|
| July 21, 2026 | 519.67M |
| July 20, 2026 | 505.84M |
| July 17, 2026 | 532.01M |
| July 16, 2026 | 523.78M |
| July 15, 2026 | 546.96M |
| July 14, 2026 | 544.72M |
| July 13, 2026 | 546.59M |
| July 10, 2026 | 567.90M |
| July 09, 2026 | 577.62M |
| July 08, 2026 | 585.10M |
| July 07, 2026 | 544.35M |
| July 06, 2026 | 580.61M |
| July 02, 2026 | 564.53M |
| July 01, 2026 | 569.77M |
| June 30, 2026 | 612.76M |
| June 29, 2026 | 560.80M |
| June 26, 2026 | 530.51M |
| June 25, 2026 | 499.48M |
| June 24, 2026 | 479.29M |
| June 23, 2026 | 445.27M |
| June 22, 2026 | 434.43M |
| June 18, 2026 | 446.39M |
| June 17, 2026 | 454.62M |
| June 16, 2026 | 463.59M |
| June 15, 2026 | 475.56M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 15.58M |
| CNBX Pharmaceuticals, Inc. | 0.2214M |
| GB Sciences, Inc. | 0.1221M |
| Arvinas, Inc. | 608.92M |
| Fulcrum Therapeutics, Inc. | 294.08M |
Market Cap Related Metrics
| Price to Book Value | 2.675 |
| Price | 17.04 |
| Earnings Yield | -10.19% |